http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 07 Jul 2026 21:28:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scilex+Holding+Co+++++++++For%3A+Jul+03++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743125.html si-local-file:///var/storage/secattach/20260707/26743125.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scilex+Holding+Co+++++++++For%3A+Jul+03++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743125.html Tue, 07 Jul 2026 21:28:00 -0400 O.49500138 SCLX http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scilex+Holding+Co+++++++++For%3A+Jul+03++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743125.html si-local-file:///var/storage/secattach/20260707/26743125.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Scilex+Holding+Co+++++++++For%3A+Jul+03++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743125.html Tue, 07 Jul 2026 21:28:00 -0400 O.49500138 SCLX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Scilex+Holding+Co++++++++++++++++++++++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743126.html si-local-file:///var/storage/secattach/20260707/26743126.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Scilex+Holding+Co++++++++++++++++++++++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743126.html Tue, 07 Jul 2026 21:28:00 -0400 O.49500138 SCLX http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Scilex+Holding+Co++++++++++++++++++++++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743126.html si-local-file:///var/storage/secattach/20260707/26743126.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13DA++Scilex+Holding+Co++++++++++++++++++++++Filed+by%3A+SCLX+Stock+Acquisition+JV+LLC/26743126.html Tue, 07 Jul 2026 21:28:00 -0400 O.49500138 SCLX http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html <p>Semnur Pharmaceuticals, Inc. (OTC: SMNR), a majority-owned subsidiary of Scilex Holding Company (NASDAQ: SCLX), has signed a binding term sheet for a proposed $100 million strategic investment from iHolding Group LLP, a private investment group based in Almaty, Kazakhstan.</p> <p>Under the terms of the agreement, iHolding would purchase approximately 10 million newly issued shares of Semnur common stock at $10.00 per share. The proposed funds would be directed toward advancing Semnur's pipeline, including its ongoing Phase 3 clinical program for SEMDEXA (SP-102), a non-opioid gel formulation administered epidurally for moderate to severe chronic radicular pain. Additional uses would include product development, http://www.streetinsider.com/Corporate+News/Semnur+signs+%24100M+binding+term+sheet+with+Kazakhstan+investor/26737707.html Tue, 07 Jul 2026 06:00:14 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Press+Releases/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html <p>PALO ALTO, Calif., July 07, 2026 (GLOBE NEWSWIRE) -- Semnur Pharmaceuticals, Inc. (“Semnur” or the “Company”) (OTC: SMNR) , a clinical late-stage specialty pharmaceutical company focused on the development and commercialization of novel non-opioid pain therapies, today announced the signing of a binding term sheet with iHolding Group LLP (“iHolding”), a private investment group headquartered in Almaty, Republic of Kazakhstan. The term sheet contemplates that iHolding will purchase $100,000,000 of newly issued shares of Semnur common stock. The purchase price for such shares is expected to be $10.00 per share, which would represent approximately 10,000,000 shares.</p> <p>The http://www.streetinsider.com/Globe+Newswire/Semnur+Pharmaceuticals%2C+Inc.+%28%E2%80%9CSemnur%E2%80%9D%29%2C+a+Majority-Owned+Subsidiary+of+Scilex+Holding+Company+%28Nasdaq%3A+SCLX%2C+%E2%80%9CScilex%E2%80%9D%29%2C+Announces+Signing+of+Binding+Term+Sheet+for+Proposed+%24100+Million+Strat/26737703.html Tue, 07 Jul 2026 06:00:00 -0400 A.06822034 O.06084726 O.20026344 O.49500138 O.55607666 SCLX SMNR SRNEQ